Exenatide Response in an Adolescent’s Morbid Obesity
نویسندگان
چکیده
منابع مشابه
Morbid Obesity in Diabetes Mellitus Type 2 and Exenatide
Worldwide, the prevalence of diabetes and obesity is increasing in recent years in developed countries. The first step of treatment is changes in lifestyle and in case of failure to initiate drug treatment. In our case, the patient with morbid obesity and glucose intolerance to metformin therapy was initiated without achieving weight loss and loss of glycemic control after 6 months of treatment...
متن کاملExenatide Effects on Cardiometabolic Risk and Weight in Adolescents with Morbid Obesity and Type 2 Diabetes Mellitus: Two Case Reports
OBJECTIVE Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control and cardiometabolic risk factors in adults with type 2 diabetes mellitus, but pediatric data is sparse. RESEARCH DESIGN AND METHODS This is the first report to describe the effects of GLP-1 receptor agonist Exenatide on metabolic risk and weight in adolescents with morbid obesity (BMI>35kg/m2) and type 2 diab...
متن کاملIntracranial Lesions in Children and Adolescents with Morbid Obesity
BACKGROUND Intracranial lesions may affect the hypothalamo-hypophyseal axis and lead to some neuro-endocrinological dysfunctions (hyperphagia, sleep disorders and hormonal dysfunctions). There is a very limited number of studies about childhood obesity and intracranial lesions. AIMS To evaluate the incidence of intracranial lesions and its role in clinical symptoms and aetiology in cases with...
متن کاملSibutramine as an adjuvant therapy in adolescents suffering from morbid obesity.
BACKGROUND The prevalence of morbid obesity is increasing rapidly. Weight reduction is very difficult using diet restriction and physical activity alone. Sibutramine has been shown to be effective and safe as an adjuvant therapy to diet restrictions. OBJECTIVES To describe our experience using sibutramine in weight reduction treatment of adolescents suffering from morbid obesity. METHODS Th...
متن کاملGastrointestinal Symptoms in Morbid Obesity
BACKGROUND Several reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and because there are limited clinic-based studies, we documented the prevalence of upper and lower GI symptoms in morbidly obese individuals in a clinic setting. OBJECTIVE The aim of our study w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacology & Pharmacy
سال: 2014
ISSN: 2157-9423,2157-9431
DOI: 10.4236/pp.2014.54051